Bausch + Lomb Corp. announced an amendment to the employment agreement with its CEO, Brenton L. Saunders, on July 21, 2025. The amendment modifies Mr. Saunders' "good reason" severance rights related to the company's spin-off from Bausch Health Companies Inc. Additionally, the terms of Saunders' performance stock units have been revised. These units will now vest and payout between 120% and 330% of the target by February 23, 2029, based on achieving specific share-price hurdles and a new cumulative Adjusted EBITDA performance goal for the fiscal years 2025-2028. The full text of these amendments will be available in the company's upcoming Quarterly Report on Form 10-Q.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。